Skip to main content
. 2017 Feb 15;13(5):955–966. doi: 10.1080/15548627.2017.1287652

Figure 5.

Figure 5.

Atg5 or Rb1cc1 deficiency does not affect the lysosomal degradation pathway. (A) MA9 wild-type, MA9-atg5−/− and MA9-rb1cc1/ leukemia cells were treated with chloroquine at 25 μM for 6 h followed by TEM imaging. Scale bar: 500 nm. (B) MA9 wild-type, MA9-atg5−/− and MA9-rb1cc1/ leukemia cells cultured under basal condition were harvested and used for western blot analysis (n = 2 repeats).